{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:43:36Z","timestamp":1791420216162,"version":"4.3.3"},"reference-count":36,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,4,1]]},"abstract":"<jats:p>OBJECTIVE. We evaluated the impact of fluconazole prophylaxis for extremely low birth weight infants on invasive candidiasis incidence, invasive candidiasis-related mortality rates, and fluconazole susceptibility of Candida isolates.<\/jats:p>\n               <jats:p>METHODS. Extremely low birth weight infants &amp;lt;5 days of age, except those with liver dysfunction, were eligible for fluconazole prophylaxis. NICU infants (all birth weights) with invasive candidiasis between April 2002 and March 2006 were compared with those with invasive candidiasis before fluconazole prophylaxis (2000\u20132001).<\/jats:p>\n               <jats:p>RESULTS. Twenty-two infants had invasive candidiasis (all candidemia) during fluconazole prophylaxis; before fluconazole prophylaxis, there were 19 cases (candidemia: 17 cases; meningitis: 2 cases). Invasive candidiasis incidence in NICU infants decreased from 0.6% (19 of 3012 infants) before fluconazole prophylaxis to 0.3% (22 of 6393 infants) in 2002\u20132006 and that in extremely low birth weight infants decreased 3.6-fold. No Candida-attributable deaths occurred during 2002\u20132006 fluconazole prophylaxis, compared with 4 (21%) before fluconazole prophylaxis. The onset of invasive candidiasis was later during 2002\u20132006 (23.5 vs 12 days), but risk factors were similar. The invasive candidiasis species distribution remained stable. Of 409 infants who received fluconazole prophylaxis, 119 (29%) received 42 days. Shorter fluconazole prophylaxis duration was related to intravenous access no longer being necessary in 242 cases (59%), noninvasive candidiasis-related death in 29 (7%), hospital transfer in 8 (2%), invasive candidiasis diagnosis in 8 (2%), and transient increase in serum transaminase levels in 4 (1%). One hundred twenty-seven infants (31%) who received fluconazole prophylaxis developed cholestasis during hospitalization, two thirds of whom had other predisposing conditions. On multivariate logistic regression necrotizing enterocolitis and increasing days of total parenteral nutrition, but not increasing number of doses on days of fluconazole, were significantly associated with the development of cholestasis.<\/jats:p>\n               <jats:p>CONCLUSION. During 4 years of fluconazole prophylaxis, the incidence of invasive candidiasis and invasive candidiasis-associated mortality rates in extremely low birth weight infants were reduced significantly, without the emergence of fluconazole-resistant Candida species.<\/jats:p>","DOI":"10.1542\/peds.2007-1130","type":"journal-article","created":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T20:25:58Z","timestamp":1207081558000},"page":"703-710","source":"Crossref","is-referenced-by-count":134,"title":["Fluconazole Prophylaxis in Extremely Low Birth Weight Neonates Reduces Invasive Candidiasis Mortality Rates Without Emergence of Fluconazole-Resistant <i>Candida<\/i> Species"],"prefix":"10.1542","volume":"121","author":[{"given":"C. Mary","family":"Healy","sequence":"first","affiliation":[{"name":"Departments of Pediatrics"},{"name":"Woman's Hospital of Texas, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith R.","family":"Campbell","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics"},{"name":"Woman's Hospital of Texas, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Zaccaria","sequence":"additional","affiliation":[{"name":"Woman's Hospital of Texas, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol J.","family":"Baker","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics"},{"name":"Woman's Hospital of Texas, Houston, Texas"},{"name":"Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2008,4,1]]},"reference":[{"key":"2021120902095152400_R1","doi-asserted-by":"crossref","unstructured":"Butler KM, Baker CJ. Candida: an increasingly important pathogen in the nursery. Pediatr Clin North Am.\u20081988;35(3):543\u2013563","DOI":"10.1016\/S0031-3955(16)36471-9"},{"key":"2021120902095152400_R2","doi-asserted-by":"crossref","unstructured":"Stoll BJ, Gordon T, Korones SB, et al. Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr.\u20081996;129(1):63\u201371","DOI":"10.1016\/S0022-3476(96)70191-9"},{"key":"2021120902095152400_R3","doi-asserted-by":"crossref","unstructured":"Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics.\u20082002;110(2):285\u2013291","DOI":"10.1542\/peds.110.2.285"},{"key":"2021120902095152400_R4","doi-asserted-by":"crossref","unstructured":"Fridkin SK, Kaufman D, Edwards JR, Shetty S, Horan T. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995\u20132004. Pediatrics.\u20082006;117(5):1680\u20131687","DOI":"10.1542\/peds.2005-1996"},{"key":"2021120902095152400_R5","doi-asserted-by":"crossref","unstructured":"Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Donowitz LG. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med.\u20082001;345(23):1660\u20131666","DOI":"10.1056\/NEJMoa010494"},{"key":"2021120902095152400_R6","doi-asserted-by":"crossref","unstructured":"Noyola DE, Fernandez M, Moylett EH, Baker CJ. Ophthalmologic, visceral, and cardiac involvement in neonates with candidemia. Clin Infect Dis.\u20082001;32(7):1018\u20131023","DOI":"10.1086\/319601"},{"key":"2021120902095152400_R7","doi-asserted-by":"crossref","unstructured":"Kossoff EH, Buescher ES, Karlowicz MG. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J.\u20081998;17(6):504\u2013508","DOI":"10.1097\/00006454-199806000-00014"},{"key":"2021120902095152400_R8","doi-asserted-by":"crossref","unstructured":"Benjamin DK Jr, DeLong ER, Steinbach WJ, Cotton CM, Walsh TJ, Clark RH. Empirical therapy for neonatal candidemia in very low birth weight infants. Pediatrics.\u20082003;112(3):543\u2013547","DOI":"10.1542\/peds.112.3.543"},{"key":"2021120902095152400_R9","doi-asserted-by":"crossref","unstructured":"Saiman L, Ludington E, Pfaller M, et al. Risk factors for candidemia in neonatal intensive care unit patients: the National Epidemiology of Mycosis Survey Study Group. Pediatr Infect Dis J.\u20082000;19(4):319\u2013324","DOI":"10.1097\/00006454-200004000-00011"},{"key":"2021120902095152400_R10","doi-asserted-by":"crossref","unstructured":"Chapman RL, Faix RG. Persistently positive cultures and outcome in invasive neonatal candidiasis. Pediatr Infect Dis J.\u20082000;19(9):822\u2013827","DOI":"10.1097\/00006454-200009000-00003"},{"key":"2021120902095152400_R11","doi-asserted-by":"crossref","unstructured":"Stoll BJ, Hansen NI, Adams-Chapman I, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA.\u20082004;292(19):2357\u20132365","DOI":"10.1001\/jama.292.19.2357"},{"key":"2021120902095152400_R12","doi-asserted-by":"crossref","unstructured":"Benjamin DK Jr, Stoll BJ, Fanaroff AA, et al. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics.\u20082006;117(1):84\u201392","DOI":"10.1542\/peds.2004-2292"},{"key":"2021120902095152400_R13","doi-asserted-by":"crossref","unstructured":"Smith PB, Morgan J, Benjamin DK, et al. Excess costs of hospital care associated with neonatal candidemia. Pediatr Infect Dis J.\u20082007;26(3):197\u2013200","DOI":"10.1097\/01.inf.0000253973.89097.c0"},{"key":"2021120902095152400_R14","doi-asserted-by":"crossref","unstructured":"Pappas PG, Rex JH, Sobel JD, et al. Guidelines for treatment of candidiasis. Clin Infect Dis.\u20082004;38(2):161\u2013189","DOI":"10.1086\/380796"},{"key":"2021120902095152400_R15","unstructured":"American Academy of Pediatrics. Candidiasis. In: Pickering LK, Baker CJ, Long SS, McMillan JA, eds. Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2006:242\u2013246"},{"key":"2021120902095152400_R16","doi-asserted-by":"crossref","unstructured":"Kicklighter SD, Springer SC, Cox T, Hulsey TC, Turner RB. Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. Pediatrics.\u20082001;107(2):293\u2013298","DOI":"10.1542\/peds.107.2.293"},{"key":"2021120902095152400_R17","doi-asserted-by":"crossref","unstructured":"McGuire W, Clerihew L, Austin N. Prophylactic intravenous antifungal agents to prevent mortality and morbidity in very low birth weight infants. Cochrane Database Syst Rev.\u20082004; (1):CD003850","DOI":"10.1002\/14651858.CD003850.pub2"},{"key":"2021120902095152400_R18","doi-asserted-by":"crossref","unstructured":"Kaufman D, Boyle R, Hazen KC, et al. Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of &lt;1000 grams birth weight. J Pediatr.\u20082005;147(2):172\u2013179","DOI":"10.1016\/j.jpeds.2005.03.036"},{"key":"2021120902095152400_R19","doi-asserted-by":"crossref","unstructured":"Healy CM, Baker CJ, Zaccaria E, Campbell JR. Impact of fluconazole prophylaxis on rate and outcome of invasive candidiasis in a neonatal intensive care unit. J Pediatr.\u20082005;147(2):166\u2013171","DOI":"10.1016\/j.jpeds.2005.04.016"},{"key":"2021120902095152400_R20","doi-asserted-by":"crossref","unstructured":"Manzoni P, Arissio R, Mostert M, et al. Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study. Pediatrics.\u20082006;117(1). Available at: www.pediatrics.org\/cgi\/content\/full\/117\/1\/e22","DOI":"10.1542\/peds.2004-2227"},{"key":"2021120902095152400_R21","doi-asserted-by":"crossref","unstructured":"Bertini G, Perugi S, Dani C, et al. Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants. J Pediatr.\u20082005;147(2):162\u2013165","DOI":"10.1016\/j.jpeds.2005.02.020"},{"key":"2021120902095152400_R22","doi-asserted-by":"crossref","unstructured":"Uko S, Soghier LM, Vega M, et al. Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants. Pediatrics.\u20082006;117(4):1243\u20131252","DOI":"10.1542\/peds.2005-1969"},{"key":"2021120902095152400_R23","doi-asserted-by":"crossref","unstructured":"Aghai ZH, Mudduluru M, Nakhla TA, et al. Fluconazole prophylaxis in extremely low birth weight infants: association with cholestasis. J Perinatol.\u20082006;26(9):550\u2013555","DOI":"10.1038\/sj.jp.7211570"},{"key":"2021120902095152400_R24","doi-asserted-by":"crossref","unstructured":"Manzoni P, Stolfi I, Pugni L, et al. A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N Engl J Med.\u20082007;356(24):2483\u20132495","DOI":"10.1056\/NEJMoa065733"},{"key":"2021120902095152400_R25","doi-asserted-by":"crossref","unstructured":"Walsh TJ, Gonzalez CE, Piscitelli S, et al. Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasis. J Clin Microbiol.\u20082000;38(6):2369\u20132373","DOI":"10.1128\/JCM.38.6.2369-2373.2000"},{"key":"2021120902095152400_R26","doi-asserted-by":"crossref","unstructured":"Wildfeuer A, Faergemann J, Laufen H, et al. Bioavailability of fluconazole in the skin after oral medication. Mycoses.\u20081994;37(3\u20134):127\u2013130","DOI":"10.1111\/j.1439-0507.1994.tb00788.x"},{"key":"2021120902095152400_R27","doi-asserted-by":"crossref","unstructured":"Long SS, Stevenson DK. Reducing Candida infections during neonatal intensive care: management choices, infection control, and fluconazole prophylaxis. J Pediatr.\u20082005;147(2):135\u2013141","DOI":"10.1016\/j.jpeds.2005.04.033"},{"key":"2021120902095152400_R28","doi-asserted-by":"crossref","unstructured":"Fanaroff AA. Fluconazole for the prevention of fungal infections: get ready, get set, caution. Pediatrics.\u20082006;117(1):214\u2013215","DOI":"10.1542\/peds.2005-2183"},{"key":"2021120902095152400_R29","unstructured":"Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard 2nd ed. Wayne, PA: National Committee for Clinical Laboratory Standards; 2002. Clinical and Laboratory Standards Institute document M27-A2"},{"key":"2021120902095152400_R30","doi-asserted-by":"crossref","unstructured":"Manzoni P, Farina D, Leonessa M, et al. Risk factors for progression to invasive fungal infection in preterm neonates with fungal colonization. Pediatrics.\u20082006;118(6):2359\u20132364","DOI":"10.1542\/peds.2006-1311"},{"key":"2021120902095152400_R31","doi-asserted-by":"crossref","unstructured":"Feja KN, Wu F, Roberts K, et al. Risk factors for candidemia in critically ill infants: a matched case-control study. J Pediatr.\u20082005;147(2):156\u2013161","DOI":"10.1016\/j.jpeds.2005.02.021"},{"key":"2021120902095152400_R32","doi-asserted-by":"crossref","unstructured":"Cotten CM, McDonald S, Stoll B, et al. The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics.\u20082006;118(2):717\u2013722","DOI":"10.1542\/peds.2005-2677"},{"key":"2021120902095152400_R33","doi-asserted-by":"crossref","unstructured":"Burwell LA, Kaufman D, Blakely J, Stoll BJ, Fridkin SK. Antifungal prophylaxis to prevent neonatal candidiasis: a survey of perinatal physician practices. Pediatrics.\u20082006;118(4). Available at: www.pediatrics.org\/cgi\/content\/full\/118\/4\/e1019","DOI":"10.1542\/peds.2006-0446"},{"key":"2021120902095152400_R34","doi-asserted-by":"crossref","unstructured":"Kaufman DA, Gurka MJ, Hazen KC, et al. Patterns of fungal colonization in preterm infants weighing less than 1000 grams at birth. Pediatr Infect Dis J.\u20082006;25(8):733\u2013737","DOI":"10.1097\/01.inf.0000226978.96218.e6"},{"key":"2021120902095152400_R35","doi-asserted-by":"crossref","unstructured":"Yoder BA, Sutton DA, Winter V, Coalson JJ. Resistant Candida parapsilosis associated with long term fluconazole prophylaxis in an animal model. Pediatr Infect Dis J.\u20082004;23(7):687\u2013688","DOI":"10.1097\/01.inf.0000128777.22022.47"},{"key":"2021120902095152400_R36","doi-asserted-by":"crossref","unstructured":"Christensen RD, Henry E, Wiedneier SE, Burnett J, Lambert DK. Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease. J Perinatol.\u20082007;27(5):284\u2013290","DOI":"10.1038\/sj.jp.7211686"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/121\/4\/703\/1122232\/zpe00408000703.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/121\/4\/703\/1122232\/zpe00408000703.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T09:38:47Z","timestamp":1639042727000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/121\/4\/703\/70800\/Fluconazole-Prophylaxis-in-Extremely-Low-Birth"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,1]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2008,4,1]]},"published-print":{"date-parts":[[2008,4,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2007-1130","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,1]]}}}